Table 3.

Secondary process measures and clinical outcomes pre-Intervention and during the study period

Variable	Control clinic		Intervention clinic
	Pre-intervention	During the study period	Pre-intervention	During the study period
Last BP <130/80 mmHg	0.39 (0.33, 0.45)	0.41 (0.36, 0.46)	0.44 (0.38, 0.50)	0.44 (0.39, 0.49)
% of subjects with lab test in the last year
Phosphorus	0.66 (0.60, 0.72)	0.70 (0.66, 0.75)	0.59 (0.53, 0.65)	0.75 (0.71, 0.79)*
Urine protein	0.72 (0.67, 0.78)	0.72 (0.67, 0.76)	0.56 (0.50, 0.62)	0.63 (0.58, 0.68)*
Hemoglobin	0.82 (0.76, 0.86)	0.80 (0.76, 0.84)	0.85 (0.80, 0.89)	0.84 (0.79, 0.87)
Subjects on a diuretic	0.71 (0.66, 0.76)	0.68 (0.63, 0.72)	0.77 (0.72, 0.81)	0.75 (0.71, 0.79)
Subjects on an ACEI/ARB	0.81 (0.76, 0.85)	0.75 (0.71, 0.79)*	0.77 (0.72, 0.82)	0.78 (0.74, 0.82)
Subjects with diabetes or proteinuria on an ACEI/ARB	0.89 (0.84, 0.93)	0.85 (0.80, 0.89)	0.86 (0.78, 0.91)	0.88 (0.83, 0.92)

* P value < 0.05 pre-intervention to study period within clinic.